157
Participants
Start Date
April 30, 2007
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Atorvastatin 20 mg
AEGR-733 5 mg
AEGR-733 10 mg
Placebo
AEGR-733 5 mg + atorvastatin 20 mg
AEGR-733 10 mg + atorvastatin 20 mg
Health Trends Research, Baltimore
National Clinical Research, Richmond
Hampton Roads Center for Clinical Research, Norfolk
Piedmont Medical Research Associates, Winston-Salem
Coastal Carolina Research Center, Goose Creek
North Georgia Clinical Research, Woodstock
Jacksonville Center for Clinical research, Jacksonville
Jacksonville Center For Clinical Research, Jacksonville
Renstar Medical Research, Ocala
Medical Affiliated Research Center, Huntsville
Sterling Research Group, Cincinnati
Midwest Institute for Clinical Research, Indianapolis
Medsphere Medical Research Center, Evansville
Radiant Research, Chicago
Dallas Diabetes and Endocrine Center, Dallas
Diabetes and Glandular Disease Research, Dallas
Maine Research Associates, Auburn
Lead Sponsor
Aegerion Pharmaceuticals, Inc.
INDUSTRY